EIQ.AX is trading 28.6% up today at A$1.59 after announcing a strategic funding and U.S. commercial partnership with Pro Medicus.
- The deal includes up to A$20 million in secured convertible notes and a proposed reseller arrangement for Echo IQ’s AI cardiology products in the U.S. market.
- Investors are repricing the stock on a significantly stronger balance sheet, a clear commercialisation runway, and strategic validation from a major healthcare imaging partner.